Zobrazeno 1 - 10
of 349
pro vyhledávání: '"Hugo Cerecetto"'
Publikováno v:
Memorias del Instituto de Investigaciones en Ciencias de la Salud, Vol 22, Iss 1 (2024)
Trypanosoma cruzi es el agente causal de la enfermedad de Chagas. En Paraguay se estima que existen 165.000 personas infectadas y actualmente la principal vía de transmisión es la congénita, con una prevalencia del 5% y con alrededor de 400 niños
Externí odkaz:
https://doaj.org/article/0488908e88f4494886804d1b968d9295
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 60 (2024)
Abstract The goal of this work is to identify new fatty acid-mimetic 99mTc-complexes to be used as myocardial imaging agents that allow studying heart abnormalities in high-risk patients. In this sense, we designed a fatty acid-mimetic substructure i
Externí odkaz:
https://doaj.org/article/886b75ec05ee48d793652602f97d5f9f
Autor:
Estefanía Sicco, Amy Mónaco, Marcelo Fernandez, María Moreno, Victoria Calzada, Hugo Cerecetto
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Melanoma is one of the most aggressive and deadly skin cancers, and although histopathological criteria are used for its prognosis, biomarkers are necessary to identify the different evolution stages. The applications of molecular imaging in
Externí odkaz:
https://doaj.org/article/c958ece4803f481694033d1c6c09e6fd
Autor:
Nicole Lecot, Gonzalo Rodríguez, Valentina Stancov, Marcelo Fernández, Mercedes González, Romina J. Glisoni, Pablo Cabral, Hugo Cerecetto
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 58 (2022)
Abstract In recent years, nanocarriers have been studied as promising pharmaceutical tools for controlled drug-delivery, treatment-efficacy follow-up and disease imaging. Among them, X-shaped amphiphilic polymeric micelles (Tetronic®, poloxamines) d
Externí odkaz:
https://doaj.org/article/afbe30a77c4f4d8790569ce988c78676
Autor:
Elena Aguilera, Carina Sánchez, María Eugenia Cruces, Belén Dávila, Lucía Minini, Florencia Mosquillo, Leticia Pérez-Díaz, Elva Serna, Susana Torres, Alicia Schini, Luis Sanabria, Ninfa I. Vera de Bilbao, Gloria Yaluff, Flavio R. Zolessi, Luis Fabian Ceilas, Hugo Cerecetto, Guzmán Alvarez
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 20 (2022)
Chagas disease is caused by the protozoan Trypanosoma cruzi (T. cruzi). It remains the major parasitic disease in Latin America and is spreading worldwide, affecting over 10 million people. Hundreds of new compounds with trypanosomicidal action have
Externí odkaz:
https://doaj.org/article/1e23890425284d1381d54bf2743249aa
Autor:
Fabiana Gomes Nascimento Soares, Gabriela Göethel, Luciano Porto Kagami, Gustavo Machado das Neves, Elisa Sauer, Estefania Birriel, Javier Varela, Itamar Luís Gonçalves, Gilsane Von Poser, Mercedes González, Daniel Fábio Kawano, Fávero Reisdorfer Paula, Eduardo Borges de Melo, Solange Cristina Garcia, Hugo Cerecetto, Vera Lucia Eifler-Lima
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss S1, Pp 1-13 (2019)
Abstract Background Chagas disease (CD) is a tropical parasitic disease. Although the number of people infected is very high, the only drugs available to treat CD, nifurtimox (Nfx) and benznidazole, are highly toxic, particularly in the chronic stage
Externí odkaz:
https://doaj.org/article/a1155bc5da654d5b82d957fc9d855049
Autor:
Gabriela Casanova, Juan Carlos Rosillo, Marcie Jiménez, Anabel Fernández, Magela Rodao, Gaby Martínez, Eugenia Isasi, Nadia Presa Gau, Gabriel Otero, Mauricio Cabrera, Pablo Díaz‐Amarilla, Hugo Cerecetto, Mercedes González, Silvia Olivera‐Bravo
Publikováno v:
International Journal of Developmental Neuroscience. 83:274-296
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5e456ff400ca08dcdb7d0cc40fa9090
https://doi.org/10.1002/jdn.10256
https://doi.org/10.1002/jdn.10256
Publikováno v:
Chemical Biology & Drug Design. 101:1435-1445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e2dd6a4dced32003ba332478a5cb76f
https://doi.org/10.1111/cbdd.14208
https://doi.org/10.1111/cbdd.14208
Publikováno v:
Molecular Systems Design & Engineering. 8:358-378
A high-CT organic fluorophore featuring an internal weak basic moiety to promote a selectively diverse PCET mechanism upon excitation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b3d877ead176c0fedd9d2caae3e4fac
https://doi.org/10.1039/d2me00182a
https://doi.org/10.1039/d2me00182a
Autor:
Germán Fuentes, María F. García, Hugo Cerecetto, Guzmán Álvarez, Marcos Couto, Angel H. Romero
Publikováno v:
Organic & Biomolecular Chemistry. 21:3660-3668
A novel efficient one-step synthetic strategy for the preparation of the antiviral favipiravir from with the available 3-hydroxy-2-pyrazinecarboxamide and Selectfluor® was developed, the use of an IL being essential.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44937287c0b93e36b196d64a1e650187
https://doi.org/10.1039/d3ob00380a
https://doi.org/10.1039/d3ob00380a